Response was ongoing in 1 patient, who had a duration of response of 19.4 months at data cutoff (Fig. 1); this was a man aged 63 years with a PD-L1− tumor who had received prior treatment with cisplatin, etoposide, and mitotane and had target lesions in the liver and lymph node (Additional file 1: Figure S1). This evidence concerns the gene CD274 and neoplasm.